The IMA Group strengthens its presence in the pharma and consumer goods sectors On August 1st 2024, IMA Group, through the new established IMA Sarong, completed the closing for the acquisition of the…
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…